Insmed, Inc. (INSM)
121.90
+3.36
(+2.83%)
USD |
NASDAQ |
Aug 31, 16:00
122.10
+0.20
(+0.17%)
After-Hours: 17:28
Insmed Cash from Operations (Annual) : -935.01M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -935.01M |
| December 31, 2024 | -683.88M |
| December 31, 2023 | -536.25M |
| December 31, 2022 | -400.44M |
| December 31, 2021 | -363.30M |
| December 31, 2020 | -219.35M |
| December 31, 2019 | -250.65M |
| December 31, 2018 | -257.98M |
| December 31, 2017 | -159.62M |
| December 31, 2016 | -146.71M |
| December 31, 2015 | -100.70M |
| December 31, 2014 | -64.42M |
| December 31, 2013 | -46.66M |
| Date | Value |
|---|---|
| December 31, 2012 | -31.01M |
| December 31, 2011 | -30.20M |
| December 31, 2010 | -7.722M |
| December 31, 2009 | -11.01M |
| December 31, 2008 | -11.99M |
| December 31, 2007 | -25.26M |
| December 31, 2006 | -42.20M |
| December 31, 2005 | -27.76M |
| December 31, 2004 | -24.90M |
| December 31, 2003 | -10.76M |
| December 31, 2002 | -24.08M |
| December 31, 2001 | -31.78M |
| December 31, 2000 | -21.42M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Biogen, Inc. | 2.205B |
| Gilead Sciences, Inc. | 10.02B |
| Agios Pharmaceuticals, Inc. | -372.98M |